Allogene Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Allogene Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Allogene Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Allogene Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $862k | 353k | 2.44 |
| 2025-03-31 | $1.0M | 689k | 1.46 |
| 2024-12-31 | $1.5M | 716k | 2.13 |
| 2024-09-30 | $1.3M | 469k | 2.79 |
| 2024-06-30 | $175k | 75k | 2.33 |
| 2024-03-31 | $3.0M | 678k | 4.47 |
| 2023-12-31 | $110k | 34k | 3.21 |
| 2023-09-30 | $1.1M | 339k | 3.18 |
| 2023-03-31 | $2.7M | 555k | 4.94 |
| 2022-12-31 | $2.2M | 344k | 6.29 |
| 2022-09-30 | $5.7M | 518k | 11.01 |
| 2021-12-31 | $3.7M | 265k | 13.79 |
| 2021-03-31 | $4.4M | 124k | 35.30 |
| 2020-12-31 | $570k | 23k | 25.25 |
| 2020-09-30 | $406k | 11k | 37.69 |
| 2020-06-30 | $2.1M | 50k | 42.88 |
| 2020-03-31 | $887k | 46k | 19.45 |
| 2019-12-31 | $1.2M | 45k | 26.00 |
| 2019-09-30 | $1.2M | 42k | 27.25 |
| 2019-06-30 | $2.5M | 93k | 26.85 |
| 2019-03-31 | $112k | 3.9k | 28.71 |
| 2018-12-31 | $152k | 5.6k | 27.01 |